Cardiol Therapeutics (CRDL) Operating Income (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Operating Income came in at -$7.1 million in Q1 2026, down 20.49% YoY from -$8.9 million in Q1 2025, and down 20.49% on a QoQ basis from -$5.9 million in Q1 2025.
Cardiol Therapeutics (CRDL) Operating Income (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 6 years of Operating Income data on file, last reported at -$7.1 million in Q1 2026.
- Quarterly Operating Income fell 20.49% year-over-year to -$7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$25.9 million (up 10.56% YoY) and the FY2025 annual result came in at -$24.6 million, up 14.65% from the prior year.
- Operating Income declined to -$7.1 million in Q1 2026, from -$5.9 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$5.9 million in Q1 2025 to a low of -$10.1 million in Q3 2022.
- A 4-year average of -$7.3 million and a median of -$7.1 million in 2026 frame the typical range for Operating Income.
- The widest YoY moves for Operating Income: up 35.52% in 2022, down 38.57% in 2022.
- Tracing CRDL's Operating Income over 4 years: stood at -$6.7 million in 2022, then gained by 6.9% to -$6.2 million in 2024, then grew by 5.83% to -$5.9 million in 2025, then fell by 20.49% to -$7.1 million in 2026.
- The last three Operating Income figures came in at -$7.1 million (Q1 2026), -$5.9 million (Q1 2025), and -$6.2 million (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.08 Mn |
| Mar 31, 2025 | -5.87 Mn |
| Mar 31, 2024 | -6.24 Mn |
| Dec 31, 2022 | -6.70 Mn |
| Sep 30, 2022 | -10.14 Mn |
| Jun 30, 2022 | -7.24 Mn |
| Mar 31, 2022 | -7.73 Mn |
| Dec 31, 2021 | -10.39 Mn |
| Sep 30, 2021 | -8.07 Mn |
| Jun 30, 2021 | -5.23 Mn |
| Mar 31, 2021 | -7.10 Mn |
| Dec 31, 2020 | -7.38 Mn |
| Sep 30, 2020 | -3.31 Mn |
| Jun 30, 2020 | -2.58 Mn |